Codexis Partners with Axolabs to Advance Oligonucleotide Manufacturing Through ECO Synthesis® Codexis, Inc. has signed an evaluation agreement with Axolabs, enhancing the ECO Synthesis® platform for improved oligonucleotide therapeutics manufacturing.

Codexis Partners with Axolabs to Advance Oligonucleotide Manufacturing Through ECO Synthesis® #USA #Redwood_City #Codexis #ECO_Synthesis #Axolabs